Evidence map›Paper›PMID 27049393›Full record

ArticleMarine drugs2016

New Cyclic Lipopeptides of the Iturin Class Produced by Saltern-Derived Bacillus sp. KCB14S006.

Sangkeun Son, Sung-Kyun Ko, Mina Jang, Jong Won Kim, Gil Soo Kim, Jae Kyoung Lee, Eun Soo Jeon, Yushi Futamura, In-Ja Ryoo, Jung-Sook Lee and 7 more

Abstract read
In one paragraph

Article in Marine drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Antimicrobial Activity ofInternational journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. The Profile and Antimicrobial Activity ofFrontiers in microbiology · 2017
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sangkeun SonAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. sonski@kribb.re.kr.
Sung-Kyun KoAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. ksk1230@kribb.re.kr.
Mina JangAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. jangmina@kribb.re.kr.
Jong Won KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. jwkim@kribb.re.kr.
Gil Soo KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. sssktu@kribb.re.kr.
Jae Kyoung LeeAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. scarscar@kribb.re.kr.
Eun Soo JeonAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. eunsooj@kribb.re.kr.
Yushi FutamuraChemical Biology Research Group, RIKEN Center for Sustainable Research Science, Saitama 351-0198, Japan. futamuray@riken.jp.
In-Ja RyooAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. ijryoo@kribb.re.kr.
Jung-Sook LeeUniversity of Science and Technology (UST), Daejeon 305-333, Korea. jslee@kribb.re.kr.
Hyuncheol OhCollege of Pharmacy, Wonkwang University, Iksan 570-749, Korea. hoh@wonkwang.ac.kr.
Young-Soo HongAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. hongsoo@kribb.re.kr.
Bo Yeon KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. bykim@kribb.re.kr.
Shunji TakahashiChemical Biology Research Group, RIKEN Center for Sustainable Research Science, Saitama 351-0198, Japan. shunjitaka@riken.jp.
Hiroyuki OsadaChemical Biology Research Group, RIKEN Center for Sustainable Research Science, Saitama 351-0198, Japan. hisyo@riken.jp.
Jae-Hyuk JangAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. jangjh@kribb.re.kr.
Jong Seog AhnAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 363-883, Korea. jsahn@kribb.re.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salterns, one of the most extreme natural hypersaline environments, are a rich source of halophilic and halotolerant microorganisms, but they remain largely underexplored ecological niches in the discovery of bioactive secondary metabolites. In continued efforts to investigate the metabolic potential of microbial populations from chemically underexplored sites, three new lipopeptides named iturin F₁, iturin F₂ and iturin A₉ (1-3), along with iturin A₈ (4), were isolated from Bacillus sp. KCB14S006 derived from a saltern. The structures of the isolated compounds were established by 1D-, 2D-NMR and HR-ESIMS, and their absolute configurations were determined by applying advanced Marfey's method and CD spectroscopy. All isolates exhibited significant antifungal activities against various pathogenic fungi and moderate cytotoxic activities toward HeLa and src(ts)-NRK cell lines. Moreover, in an in vitro enzymatic assay, compound 4 showed a significant inhibitory activity against indoleamine 2,3-dioxygenase.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsBacillusBacteriaCell Line, TumorFungiHeLa CellsHumansLipopeptidesMagnetic Resonance SpectroscopyPeptides, CyclicAnti-Bacterial AgentsAntifungal AgentsLipopeptidesPeptides, Cyclicantifungalcytotoxicindoleamine-2,3-dioxygenaseiturinssaltern-derived bacteria

Identifiers

PMID27049393
PMCPMC4849076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.